AZoLifeSciences on MSN
The life cycle of a protein
A protein’s life is anything but simple. Discover how transcription, translation, folding, modification, and degradation work together to preserve proteome integrity.
3don MSN
'Sensory checkpoint' in adult brain keeps remodeling itself long after adolescence, scientists find
The dominant theory in neuroscience has been that the sensory processing circuits in our brain are finalized in early ...
For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives. Some of these treatments, such as Keytruda and Opdivo, have become familiar ...
News-Medical.Net on MSN
Discovery offers hope for reducing immune-related heart risks in cancer patients
For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives. Some of these treatments, such as Keytruda and Opdivo, have become familiar ...
HCB101, a novel Fc-based anti-SIRPα-CD47 fusion protein, has received orphan drug designation (ODD) from the FDA for the ...
Protein-Protein Interactions (PPIs) are critical for biological systems to function properly. Strong interactions maintain structural integrity and function, whereas weaker interactions enable ...
A research team led by Professor Ki-Young Lee at the College of Medicine, Sungkyunkwan University, has uncovered a previously unrecognized tumor-intrinsic role of the immune checkpoint molecule PD-L1, ...
Researchers identify that the brain's sensory checkpoint (TRN) undergoes a molecular "upgrade" in adulthood for high-resolution perception.
Researchers found muscle stem cells temporarily reduce PFKM-driven glucose metabolism after stress, rerouting fuel to antioxidant repair before rebuilding. Targeting this metabolic checkpoint could ...
6don MSN
Russian troops forced me to clean torture cells, Ukrainian former teen prisoner tells Euronews
FILE - Ukrainian children play at an abandoned checkpoint in Kherson, southern Ukraine, Wednesday, Nov. 23, 2022.
A Chinese phase 3 trial of Bristol Myers Squibb’s antibody-drug conjugate has hit its dual primary survival endpoints, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results